Molecular therapy for Anti-ageing and Life extension therapy: Metformin, the widely used drug in the treatment of TIIDM, increases CHIP levels, increases monoubiquitylation of insulin receptor (INSR), decreases INSR protein levels and enhances lifespan via down regulation of its target gene, 11/June/2015, 11.53 pm
https://genomediscovery.org/wp-content/uploads/2017/06/Metformin-increases-CHIP-exprssion-and-promtes-longevity.jpg
960
720
Dr Boomi's Genom-2-Discovery Center
https://genomediscovery.org/wp-content/uploads/2017/06/Metformin-increases-CHIP-exprssion-and-promtes-longevity.jpg
Introduction: What they say A study from Institute for Cell Biology, University of Bonn, Ulrich-Haberland Str. Bonn, Germany; and Institute for Genetics and CECAD Research Center, University of Cologne, Joseph-Stelzmann…
read more